INCR Intercure delivers 287 percent Q2 2023 EPS beat even as shares dip 048 percent in todays trading What could go wrong with Hercules HCXY stock Hercules posts 44 EPS miss vs consensus forecasts Bristol Myers Squibb BMY Valuation Deep Dive Assessing If The LargeCap Pharma Name Is The Best Bargain In Big Pharma